2021 U-M Kellogg Eye Center Annual Report

Page 19

MY HOPE IS THAT A BETTER

UNDERSTANDING THE GENETIC AND

MOLECULAR MECHANISMS OF SMALL EYES AND HYPEROPIA WILL POINT TO NEW

Lev Prasov, M.D., Ph.D., and Erika Ward, B.S., review a pedigree of a large family with nanophthalmos

THERAPEUTIC TARGETS FOR THESE DISEASES. — Lev Prasov, M.D., Ph.D.

Mapping the Genetic Landscape of Nanophthalmos Nanophthalmos is characterized by a small eye and severe

This grant will be used to catalog the genetic determinants

farsightedness (high hyperopia). The condition can lead to a

of nanophthalmos and high hyperopia, including describing

range of complications, from angle closure glaucoma to retinal

the mechanism by which MYRF disrupts RPE structure and

and choroidal detachments.

function.

How nanophthalmos develops is not completely under-

A team of mentors and collaborators led by Dr. Sally

stood. But an important piece of the puzzle was revealed in

Camper will support Dr. Prasov, providing instruction and

2019, when Kellogg physician-scientist Lev Prasov, M.D., Ph.D.

supervision in developmental and medical genetics, RPE biology,

first linked the gene myelin regulatory factor (MYRF) to familial

genomics and bioinformatics.

nanophthalmos. Using animal models, he also uncovered a role

“My hope is that a better understanding the genetic and

for MYRF in retinal pigment epithelial (RPE) development, find-

molecular mechanisms of small eyes and hyperopia will point

ing that its disruption led to retinal degeneration in mice.

to new therapeutic targets for these diseases,” he says. “The

Dr. Prasov has been awarded a Mentored Clinical Scientist Research Career Development (K-08) award from the National

findings may also shed useful light on the other end of the spectrum, namely, myopia that results from too large an eye.”

Institutes of Health to build on that work. “In a study of families with nanophthalmos, we found that known genes, including MYRF, were implicated in only

Dr. Prasov’s K-08 Mentor and Advisor Team:

20 percent of cases,” says Dr. Prasov. “But we hypothesize that

Sally Camper, Ph.D., Professor of Internal Medicine

the other 80 percent of cases may be explained by other, yet

Jun Li, Ph.D., Professor of Human Genetics

to be identified genes, that may be targets or interacting partners

David Zacks, M.D., Ph.D., Professor of Ophthalmology

of MYRF, whose primary function is to control expression of

and Visual Sciences

other genes.”

Robert B. Hufnagel, M.D., Ph.D., Director, Ophthalmic

Genomics Laboratory

K08 Award

17


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Toward a Therapeutic Target for Proliferative Vitreoretinopathy

2min
page 25

State-of-the-Science Microscope Gives Kellogg Researchers New Edge

2min
page 25

Michigan Medicine to Establish Neural Engineering Training Program

2min
page 21

Endocrine Society Award

1min
page 21

Leading on the National Stage

2min
page 15

Marshall Parks Lecture at AAO

1min
page 13

Prioritizing Communication for Patient Safety

2min
page 13

New Faculty Members

3min
page 42

Alumni Highlights

4min
page 39

Recognizing Distinguished Alumni Richard Gutow, M.D., and Gary Gutow, M.D.

6min
pages 36-37

Guarding Photoreceptor Metabolism to Prevent Vision Loss in Inherited Retinal Diseases

2min
page 31

Big Data, Collaboration, and Impact

3min
page 35

A Visionary Legacy

3min
page 33

Eyes on the Future

3min
page 34

Kellogg’s Latest Heed Fellows

3min
page 32

U-M Learners Produce Online Newsletter

3min
page 29

Next-Generation Tools to Treat Abnormal New Ocular Blood Vessels

3min
page 28

Genetically-Modified Occludin Shown to Protect Against Diabetes-Related Vision Loss

2min
page 30

Innovation in Action

3min
page 24

New Pediatric Ophthalmology Fellowship in Ghana

3min
page 27

Kellogg Addresses Technician Shortage with Ongoing Training Program

2min
page 26

Kellogg Researcher Launches First of-its-Kind Study of Health and Aging in Kenya

2min
page 23

A New Regulator of Retinal Angiogenesis Discovered

2min
page 22

Lipid Droplets May Protect Against AMD

2min
page 20

Mapping the Genetic Landscape of Nanophthalmos

2min
page 19

Training Eye Disease Researchers in India

2min
page 18

Kellogg Leads International Team Linking Family’s Symptoms to Rare, Inherited Syndrome

4min
pages 14-15

Clinical Research Update: Patient Perspectives

4min
page 17

Finding New Pathways for the Treatment of Choroideremia

2min
page 16

Finding a Personalized Solution for Dry Eye

3min
page 12

Vitreoretinal Lymphoma: from Symptoms to Diagnosis to Treatment

5min
pages 4-5

In it Together

5min
pages 10-11

Collaborating to Deliver Specialized Care

3min
pages 8-9

Steno North American Fellowship

2min
page 5

The Chair’s Perspective

2min
page 3

Kellogg Offers Multiple Options for Limbal Stem Cell Deficiency

3min
page 7

COVID-19 Transmission Risk in Cornea Transplantation

2min
page 9

NIH-Funded Pilot Program Addresses Disparities in Glaucoma Care

3min
page 6
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.